The Ribavirin Pregnancy Registry
Stopped Per the Division of Project Management, Office of Regulatory Operations, Office of Generic Drugs, FDA there is no regulatory requirement to continue this Registry.
Conditions
- Birth Defects
- Pregnancy Complications
- Hepatitis C
Sponsor
Syneos Health
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]